Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age 30 years and 60 years 2)Known diabetic participants with HbA1c more than equal to 7% and on OHA/insulin 3)Participants with type 2 diabetes mellitus with or without complications 4)Able to comply with the study protocol 5)Voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1)Pregnant ladies and breastfeeding mothers 2)Known cases of HIV, Chronic kidney disease on dialysis and cancer 3)Severe complications in the past six months include myocardial infarction, stroke, severe traumatic injury, major surgery. Other diseases evaluated by the investigator that are not suitable for the project 4)Likely to move away from the study site in next 01 year after.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of participants having HbA1c less than 7% over 12 monthsTimepoint: over 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucoseTimepoint: Baseline and every month till month 12;Adverse effects during the study periodTimepoint: Throughout the study;IL-6 ,CRP levelsTimepoint: Month 6 and 12;Post-prandial blood glucoseTimepoint: Baseline, Month 3,6,9,12;Proportion of participants having a reduction in dosage/withdrawal of OHA/insulinTimepoint: Over 12 months;Proportion of participants withdrawn/tapered of OHA /insulinTimepoint: over 12 months;Quality of life through TRIM-DTimepoint: Baseline, month 3,6,9,12;Symptoms through DSC-RTimepoint: Baseline, month 3,6,9,12;Telomerase activity and telomere lengthTimepoint: Baseline and month 12;Time to remission of HbA1cTimepoint: Month 3,6,9 and 12 | — |
Countries
India
Contacts
Central Council for Research in Homoeopathy